In a study presented last month at the annual meeting of the ADA, UT Southwestern researcher Ildiko Lingvay said two types of more aggressive treatments using insulin and drugs started when patients were initially diagnosed effectively preserved the function of beta cells in a study of 58 patients followed for three years.